Chinese Journal of Cancerindexed by SCI
《癌症》杂志
BMC

About the cover
About the cover

Feb. 2015; Volume 34 Issue 2

February 27, 2004, Roche announced that Genentech has received approval from the US Food and Drug Administration (FDA) for Avastin (bevacizumab, rhuMAb-VEGF), an innovative new cancer drug, to be used with intravenous 5-Fluorouracil-based chemotherapy as treatment for patients with previously untreated metastatic cancer of the colon or rectum (first-line treatment).


Review
Receptor-type protein tyrosine phosphatases in cancer
Yu Du, Jennifer R. Grandis
[ Abstract  1777]   [ PDF Full-text  1278]     [ HTML PMC ]  Page: 61-69  Epub: 2014-10-17  doi: 10.5732/cjc.014.10146
Original Article
Use of subsequent PET/CT in diffuse large B-cell lymphoma patients in complete remission following primary therapy
Xu Zhang, Wei Fan, Zhong-Jun Xia, Ying-Ying Hu, Xiao-Ping Lin, Ya-Rui Zhang, Zhi-Ming Li, Pei-Yan Liang, Yuan-Hua Li
[ Abstract  2694]   [ PDF Full-text  1705]     [ HTML PMC ]  Page: 70-78  Epub: 2014-11-21  doi: 10.5732/cjc.014.10124
Optimal follow-up duration for evaluating objective response to radiotherapy in patients with hepatocellular carcinoma: a retrospective study
Moonkyoo Kong, Seong Eon Hong
[ Abstract  1583]   [ PDF Full-text  1023]     [ HTML PMC ]  Page: 79-85  Epub: 2014-11-21  doi: 10.5732/cjc.014.10136
Survival analysis of children with stage II testicular malignant germ cell tumors treated with surgery or surgery combined with adjuvant chemotherapy
Su-Ying Lu, Xiao-Fei Sun, Zi-Jun Zhen, Zi-Ke Qin, Zhuo-Wei Liu, Jia Zhu, Juan Wang, Fei-Fei Sun
[ Abstract  1619]   [ PDF Full-text  1454]     [ HTML PMC ]  Page: 86-93  Epub: 2014-10-17  doi: 10.5732/cjc.014.10027
Case Research
Toxic epidermal necrolysis related to AP (pemetrexed plus cisplatin) and gefitinib combination therapy in a patient with metastatic non-small cell lung cancer
Ji-Jie Huang, Shu-Xiang Ma, Xue Hou, Zhao Wang, Yin-Duo Zeng, Tao Qin, Xiao-Xiao Dinglin, Li-Kun Chen
[ Abstract  2077]   [ PDF Full-text  1709]     [ HTML PMC ]  Page: 94-98  Epub: 2014-11-21  doi: 10.5732/cjc.014.10151




CJC Wechat 微信公众号

CJC触屏版


 

Editorial Manager


CJC adopts Editorial Manager to manage its submissions from Dec.18, 2014
 

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China